Stage IV Lung Cancer: Clinical Trials

27 trials for Stage IV Lung Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 9 terminated, 4 active not recruiting, 2 recruiting. 10 Not applicable, 8 Phase 2, 7 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable10Completed 4, Active not recruiting 3, Terminated 2, Unknown 1
Phase 28Terminated 5, Recruiting 2, Completed 1
Phase 17Completed 2, Recruiting 2, Terminated 2, Withdrawn 1
Phase 31Completed 1

Follow Stage IV Lung Cancer: new trials by email Literature Review of Stage IV Lung Cancer trials Research Report on Stage IV Lung Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Randomized Clinical Trial of Informational Support Versus Spiritual Care
Spiritual Care, Informational Support - Stage IV Lung Cancer, Stage IV Gastrointestinal Cancer
Not applicableActive not recruitingIndiana University432025-09-092026-10-28
Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer Survivors
Telephone based interview, Survey using a questionnaire., Electronic health record review - Stage I Lung Cancer, Stage II Lung Cancer
Not applicableTerminatedWake Forest University Health Sciences52025-06-112026-10-22
Shortened High-dose Palliative Radiotherapy for Lung Cancer
Radiotherapy - Stage IV Lung Cancer
Not applicableActive not recruitingUniversity Hospitals Coventry and Warwickshire NHS Trust372024-11-272026-10-26
A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources
Support for Caregiver - Generic List, Support for Caregiver - Personalized List, Internet-Based Intervention - CONNECT - Stage II Lung Cancer, Stage III Lung Cancer
Not applicableActive not recruitingWake Forest University Health Sciences2162024-11-112026-09-25
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Stage III Breast Cancer, Stage IV Breast Cancer
WithdrawnTravera Inc2024-11-012024-11-25
An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer
Radioconjugate, Positron Emission Tomography, Computed Tomography - Extensive-stage Small-cell Lung Cancer, Limited-stage Small-cell Lung Cancer
Phase 1WithdrawnRoswell Park Cancer Institute2024-10-012024-09-27
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Osimertinib, Osimertinib + Chemotherapy - Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation
Active not recruitingPrECOG, LLC.2002024-09-172026-09-09
Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation
Carboplatin, Atezolizumab, Etoposide - Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer
Phase 1 / Phase 2RecruitingVanderbilt-Ingram Cancer Center182024-04-242024-06-20
Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer
CIS-DPI - NSCLC (advanced Non-small Cell Lung Cancer), Stage IV Lung Cancer
Phase 1 / Phase 2RecruitingInhatarget Therapeutics322023-06-232025-03-26
Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon 14 Skipping Mutation
Capmatinib, Trametinib - Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer
Phase 1TerminatedCollin Blakely32022-08-102024-06-11
Ask Questions (ASQ):Implementation of a Communication Intervention
Behavioral Intervention - Stage II Breast Cancer, Stage III Breast Cancer
Not applicableCompletedBarbara Ann Karmanos Cancer Institute812021-08-252023-08-16
Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer
Binimetinib, Brigatinib - ALK Gene Rearrangement, Lung Non-Small Cell Carcinoma
Phase 1TerminatedUniversity of California, San Francisco32020-02-252022-10-17
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites
Canady Helios Cold Plasma Scalpel - Recurrent Malignant Solid Neoplasm, Stage IV Breast Cancer
Not applicableUnknownJerome Canady, M.D.202019-07-302021-08-09
Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer
Stereotactic Body Radiation Therapy, Pembrolizumab - Metastatic Lung Cancer, Stage IV Lung Cancer
Phase 3CompletedWake Forest University Health Sciences52019-06-242025-06-13
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners
Cognitive Behavior Therapy, Quality-of-Life Assessment, Questionnaire Administration - Malignant Female Reproductive System Neoplasm, Malignant Hepatobiliary Neoplasm
Not applicableCompletedRutgers, The State University of New Jersey142017-12-062021-04-08
Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients
Early palliative care, Routine hospice care - Stage IV Breast Cancer, Stage IV Pancreatic Cancer
CompletedSeoul National University Hospital4442016-12-172021-03-17
Truthful Information on Chemotherapy and Its Impact on Chemotherapy at the End of Life
Truthful information on chemotherapy risks, Standard of information - Stage IV Lung Cancer
Not applicableCompletedAssistance Publique - Hôpitaux de Paris1232016-07-152025-11-20
CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy
CAPP-Seq, Isovue-200, Computed Tomography Perfusion Imaging - Malignant Lung Neoplasm, Metastatic Malignant Neoplasm in the Lung
Phase 1CompletedStanford University192016-01-192023-11-22
Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer
Radiation Therapy (RT), MK-3475 - Head and Neck Squamous Cell Carcinoma, Metastatic Renal Cell Cancer
Phase 1CompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University412015-02-052025-05-15
A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations
Lucitanib - Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer
Phase 2TerminatedClovis Oncology, Inc.182014-04-012019-07-29

Showing 20 of 27. Sign in to see all of them.

Narrower conditions

Lung Neoplasms (27)  ·  Carcinoma, Non-Small-Cell Lung (10)  ·  Breast Neoplasms (5)  ·  Prostatic Neoplasms (4)  ·  Carcinoma, Renal Cell (3)  ·  Colorectal Neoplasms (3)  ·  Ovarian Neoplasms (3)  ·  Pancreatic Neoplasms (3)  ·  Small Cell Lung Carcinoma (3)  ·  Urinary Bladder Neoplasms (3)  ·  Uterine Cervical Neoplasms (3)  ·  Colonic Neoplasms (2)  ·  Liver Neoplasms (2)  ·  Melanoma (2)  ·  Stomach Neoplasms (2)

Broader conditions

Lung Diseases (27)  ·  Neoplasms by Site (27)  ·  Respiratory Tract Diseases (27)  ·  Respiratory Tract Neoplasms (27)  ·  Thoracic Neoplasms (27)  ·  Neoplasms (26)  ·  Bronchial Neoplasms (10)  ·  Carcinoma, Bronchogenic (10)  ·  Digestive System Diseases (6)  ·  Digestive System Neoplasms (6)  ·  Gastrointestinal Diseases (6)  ·  Skin Diseases (6)  ·  Skin and Connective Tissue Diseases (6)  ·  Breast Diseases (5)  ·  Female Urogenital Diseases (5)

Interventions

antineoplaston A10 (3)  ·  antineoplaston AS 2-1 (3)  ·  Carboplatin (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Radiotherapy (2)  ·  pembrolizumab (2)  ·  Behavior Therapy (1)  ·  Cisplatin (1)  ·  Cognitive Behavioral Therapy (1)  ·  Cytidine Triphosphate (1)  ·  Drug Therapy (1)  ·  E-3810 (1)  ·  Erlotinib Hydrochloride (1)  ·  Etoposide (1)  ·  Fulvestrant (1)

Sponsors

Burzynski Research Institute (3)  ·  Wake Forest University Health Sciences (3)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  Case Comprehensive Cancer Center (1)  ·  Clovis Oncology, Inc. (1)  ·  Collin Blakely (1)  ·  Indiana University (1)  ·  Inhatarget Therapeutics (1)  ·  Intergroupe Francophone de Cancerologie Thoracique (1)  ·  Jerome Canady, M.D. (1)  ·  Massachusetts General Hospital (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  PrECOG, LLC. (1)  ·  Roswell Park Cancer Institute (1)

Countries

United States (20)  ·  France (4)  ·  Spain (2)  ·  Belgium (1)  ·  Germany (1)  ·  Italy (1)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Stanislaw R. Burzynski, MD, PhD (3)  ·  Collin Blakely, MD, PhD (1)  ·  Collin M Blakely, MD, PhD (1)  ·  Evan Osmundson, MD, PhD (1)  ·  Grace Dy, MD (1)  ·  Jennifer Johnson, MD, PhD (1)  ·  Kathryn Weaver, PhD (1)  ·  Lecia V. Sequist, MD, MPH (1)  ·  Leslie B Tyson, NO (1)  ·  Mark Stevens, Ph.D. (1)  ·  Maximilian Diehn (1)  ·  Michael Farris, MD (1)

Results publications

PMID 27663515, PMID 32144133, PMID 35802350, PMID 35844029, PMID 37509349, PMID 39582048, PMID 41628919, PMID 42364728

NIH funding

P30CA012197 (2), P30CA043703 (1), P30CA072720 (1)